The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease
Julie Morisset(Centre Hospitalier de l’Université de Montréal), Joyce Lee(Inserm), Paul J. Wolters(University of California, San Francisco), Eric Vittinghoff(University of California, San Francisco), Andreina Manfredi(Azienda Ospedaliero-Universitaria di Modena), Kirk D. Jones, Brett M. Elicker, Roberto Tonelli(University of Modena and Reggio Emilia), Talmadge E. King(University of California, San Francisco), Jay H. Ryu(Mayo Clinic), Stefania Cerri(University of Modena and Reggio Emilia), Harold R. Collard(University of California, San Francisco), Andrew Gross(University Hospitals Seidman Cancer Center), Marco Sebastiani(Azienda Ospedaliero-Universitaria di Modena), Dong Soon Kim(Asan Medical Center), Brett Ley(University of California, San Francisco), Bo Young Lee(Asan Medical Center), Xiaowen Hu(Lanzhou University)
Cited by 66
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998